Form 4: Humana Executive's Routine Stock Vesting and Tax Sale

Humana's President of Insurance, George Renaudin II, reported the vesting of performance stock units and a subsequent tax-related share disposition.

Summary

• George Renaudin II, President, Insurance at Humana Inc., acquired 1,035 shares of Humana Common Stock on February 24, 2026, through the vesting of performance stock units.
• Concurrently, 419 shares were disposed of at a price of $177.075 per share to cover tax liabilities associated with this vesting event.
• Following these transactions, direct beneficial ownership for Mr. Renaudin II stands at 16,075 shares.
• Indirect holdings include 529 shares in the Humana Retirement Savings Plan and 174 Phantom Stock Units as of January 31, 2026.
• Outstanding derivative holdings include options to purchase 4,162 shares at an exercise price of $510.2425 expiring on February 24, 2030, and 6,966 shares at an exercise price of $367.21 expiring on February 21, 2031.

Sentiment

Score: 6

Explanation: StockSavvy.ai views this as a routine and expected insider transaction related to executive compensation, reflecting the achievement of performance targets and standard tax withholding, which is generally neutral to slightly positive for investor confidence.

Positives

• The vesting of 1,035 performance stock units indicates the achievement of performance targets by management, aligning executive incentives with company performance.
• The executive maintains significant equity alignment with shareholders, holding 16,075 direct shares, 9,059 restricted stock units, and additional indirect holdings and options.

Negatives

• A disposition of 419 shares occurred to cover tax liabilities, resulting in a reduction of direct beneficial ownership.

Future Outlook

The executive has future vesting increments for stock options granted in 2023 (with the final increment on February 24, 2026) and 2024 (with the final increment on February 21, 2027), indicating continued equity incentives and alignment with long-term company performance.

Industry Context

StockSavvy.ai notes that routine insider transactions, such as those related to the vesting of performance stock units and subsequent tax withholding, are common components of executive compensation structures across the healthcare insurance industry. These transactions typically reflect pre-established compensation plans rather than discretionary trading based on new material information.

Related Party Transactions

• The reported transactions involve an executive of Humana Inc. acquiring shares through a company incentive plan and disposing of shares to cover tax obligations related to that plan, which are considered related party dealings in the context of insider reporting.

Stakeholder Impact

• Shareholders: The vesting of performance stock units aligns executive incentives with shareholder value creation, while the tax-related sale is a standard practice that minimally impacts overall insider ownership.
• Employees: The executive compensation structure, including performance stock units and options, demonstrates a framework for incentivizing leadership based on performance.

Next Steps

• Future vesting of remaining stock options granted in 2023 (final increment on February 24, 2026) and 2024 (final increment on February 21, 2027).

Key Dates

Recommendation

The reported transactions are routine and compensation-related, reflecting pre-established executive incentive plans. They do not indicate a change in the company's fundamental outlook or discretionary insider sentiment that would warrant a change in investment recommendation.

Keywords

Humana, HUM, Form 4, insider transaction, stock vesting, performance stock units, executive compensation, tax withholding, stock options, restricted stock units